The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients

Quality of Life Research

Volumn 22, Issue 5, 2013, Pages 1123-1133

  Rendas Baum, Regina ^a   Bloudek, Lisa M ^b   Maglinte, Gregory A ^c   Varon, Sepideh F ^b  

^a QualityMetric Incorporated   (United States)

^b ALLERGAN INC   (United States)

^c AMGEN INC   (United States)

Author keywords

Chronic migraine; Health related quality of life; Migraine Specific Quality of Life Questionnaire (MSQ); PREEMPT; Psychometric properties; Validity

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; EQUIPMENT; FACTORIAL ANALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; MIGRAINE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; PSYCHOSIS; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOCIOECONOMICS; STANDARD; STATISTICS; DEVICES; MIGRAINE DISORDERS; PSYCHOLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CHRONIC DISEASE; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PSYCHOMETRICS; PSYCHOTIC DISORDERS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOCIOECONOMIC FACTORS;

EID: 84878714381     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-012-0230-7     Document Type: Article

References (36)

1. Dahlof, C. G. (2003). Measuring disability and quality of life in migraine. Drugs Today (Barcelona), 39(Suppl D), 17-23.
2. Dahlof, C. G.; Dimenas, E. (1995). Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia, 15(1), 31-36.
3. Freitag, F. G. (2007). The cycle of migraine: Patients' quality of life during and between migraine attacks. Clinical Therapy, 29(5), 939-949.
4. Tfelt-Hansen, P.; Block, G.; Dahlof, C.; Diener, H. C.; Ferrari, M. D.; Goadsby, P. J.; et al. (2000). Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia, 20(9), 765-786.
5. Silberstein, S.; Tfelt-Hansen, P.; Dodick, D. W.; Limmroth, V.; Lipton, R. B.; Pascual, J.; et al. (2008). Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia, 28(5), 484-495.
6. Jhingran, P.; Osterhaus, J. T.; Miller, D. W.; Lee, J. T.; Kirchdoerfer, L. (1998). Development and validation of the Migraine-Specific Quality of Life Questionnaire. Headache, 38(4), 295-302.
7. Martin, B. C.; Pathak, D. S.; Sharfman, M. I.; Adelman, J. U.; Taylor, F.; Kwong, W. J.; et al. (2000). Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ version 2.1). Headache, 40(3), 204-215.
8. Jhingran, P.; Davis, S. M.; LaVange, L. M.; Miller, D. W.; Helms, R. W. (1998). MSQ: Migraine-Specific Quality-of-Life Questionnaire. Further investigation of the factor structure 152. Pharmacoeconomics.; 13(6), 707-717.
9. Cole, J. C.; Lin, P.; Rupnow, M. F. (2007). Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment. Quality of Life Research, 16(7), 1231-1237.
10. Cole, J. C.; Lin, P.; Rupnow, M. F. (2009). Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version. Cephalalgia, 29(11), 1180-1187.
11. Bigal, M. E.; Rapoport, A. M.; Lipton, R. B.; Tepper, S. J.; Sheftell, F. D. (2003). Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: A comparison of chronic migraine with episodic migraine. Headache, 43(4), 336-342.
12. Guitera, V.; Munoz, P.; Castillo, J.; Pascual, J. (2002). Quality of life in chronic daily headache - a study in a general population. Neurology, 58(7), 1062-1065.
13. Lovati, C.; D'Amico, D.; Bertora, P.; Rosa, S.; Suardelli, M.; Mailland, E.; et al. (2008). Acute and interictal allodynia in patients with different headache forms: An Italian pilot study. Headache, 48(2), 272-277.
14. Lovati, C.; D'Amico, D.; Rosa, S.; Suardelli, M.; Mailland, E.; Bertora, P.; et al. (2007). Allodynia in different forms of migraine. Neurological Sciences, 28(Suppl 2), S220-S221.
15. Kitaj, M. B.; Klink, M. (2005). Pain thresholds in daily transformed migraine versus episodic migraine headache patients. Headache, 45(8), 992-998.
16. Bagley, C. L.; Rendas-Baum, R.; Maglinte, G. A.; Yang, M.; Varon, S. F.; Lee, J.; et al. (2011). Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache,. doi: 10.1111/j.1526-4610.
17. Adelman, J. U.; Sharfman, M.; Johnson, R.; Miller, D.; Clements, B.; Pait, G.; et al. (1996). Impact of oral sumatriptan on workplace productivity, health-related quality of life, healthcare use, and patient satisfaction with medication in nurses with migraine. The American Journal of Managed Care, 2(10), 1407-1416.
18. Cohen, J. A.; Beall, D. G.; Miller, D. W.; Beck, A.; Pait, G.; Clements, B. D. (1996). Subcutaneous sumatriptan for the treatment of migraine: Humanistic, economic, and clinical consequences. Family Medicine, 28(3), 171-177.
19. Jhingran, P.; Cady, R. K.; Rubino, J.; Miller, D.; Grice, R. B.; Gutterman, D. L. (1996). Improvements in health-related quality of life with sumatriptan treatment for migraine. Journal of Family Practice, 42(1), 36-42.
20. Aurora, S. K.; Dodick, D. W.; Turkel, C. C.; DeGryse, R. E.; Silberstein, S. D.; Lipton, R. B.; et al. (2010). OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia, 30(7), 793-803.
21. Diener, H. C.; Dodick, D. W.; Aurora, S. K.; Turkel, C. C.; DeGryse, R. E.; Lipton, R. B.; et al. (2010). OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia, 30(7), 804-814.
22. Headache Classification Subcommittee of the International Headache Society. (2004). The international classification of headache disorders: 2nd edition. Cephalalgia, 24(Suppl 1), 9-160.
23. Dahlof, C.; Bouchard, J.; Cortelli, P.; Heywood, J.; Jansen, J. P.; Pham, S.; et al. (1997). A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life. Pharmacoeconomics.; 11(Suppl 1), 24-34.
24. Martin, B. C.; Pathak, D. S.; Kwong, J.; Batenhorst, A. S.; Sharfman, M. (2003). Assessment of the responsiveness of the Migraine-Specific Quality of Life Questionnaire (version 2.1). In J. Olesen, T. J. Steiner, & R. B. Lipton (Eds.), Reducing the burden of headache (pp. 116-120). New York: Oxford University Press.
25. Ware, J. E.; Jr.; Kosinski, M.; Bjorner, J. B.; Bayliss, M. S.; Batenhorst, A.; Dahlof, C. G. H.; et al. (2003). Applications of computerized adaptive testing (CAT) to the assessment of headache impact. Quality of Life Research, 12(8), 935-952.
26. Kosinski, M.; Bayliss, M. S.; Bjorner, J. B.; Ware, J. E.; Jr, Garber, W. H.; Batenhorst, A.; et al. (2003). A six-item short-form survey for measuring headache impact: The HIT-6. Quality of Life Research, 12(8), 963-974.
27. Bayliss, M.; Batenhorst, A. (2002). The HIT-6™ a user's guide. Lincoln, RI: QualityMetric Incorporated.
28. Muthen, L. D.; Muthen, B. O. (2007). MPlus user's guide (5th ed.). Los Angeles, CA: Muthen & Muthen.
29. Hu, L.; Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1-55.
30. Anastasi, A.; Urbina, S. (1997). Psychological testing (7th ed.). Upper Saddle River, NJ: Prentice Hall.
31. Nunnally, J. C.; Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York: McGraw-Hill.
32. Ware, J. E.; Jr.; Kosinski, M.; Gandek, B.; Rogers, W.; Reese, P. R. (1997). MAP-R for Windows: multitrait/multi-Item analysis program - revised user's guide. Boston, MA: Health Assessment Lab.
33. Clark, L. A.; Watson, D. (1995). Constructing validity: Basic issues in objective scale development. Psychological Assessment, 7(3), 309-319.
34. Kerlinger, F. (1973). Foundations of behavioral research. New York: Holt, Rinehart & Winston.
35. Lipton, R. B. (2009). Tracing transformation: Chronic migraine classification, progression, and epidemiology. Neurology, 72(5 Suppl), S3-S7.
36. Cohen, J. A. (1992). A power primer. Psychological Bulletin, 112, 155-159.